Cellular mechanisms mediating the anti-invasive properties of the ornithine decarboxylase inhibitor α-difluoromethylornithine (DFMO) in human breast cancer cells

By Manni Andrea   Washington Sharlene   Mauger David   Hackett Deborah   Verderame Michael  

Clinical and Experimental Metastasis, Vol. 21, Iss. 5, 2004-12 ,pp. : 461-467

Springer Publishing Company

Access to resources Recommend Favorite

Comparative study of the immunohistochemical detection of hormone receptor status and HER-2 expression in primary and paired recurrent/metastatic lesions of patients with breast cancer

By Sari Ebru  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 57-63

Humana Press, Inc

Access to resources Recommend Favorite

Ornithine Decarboxylase (ODC) as a Prognostic Factor in Operable Breast Cancer

By Love R.R.  

Breast Cancer Research and Treatment, Vol. 79, Iss. 3, 2003-06 ,pp. : 329-334

Springer Publishing Company

Access to resources Recommend Favorite

Association between the ornithine decarboxylase G316A polymorphism and breast cancer survival

By            

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 485-491

Spandidos Publications

Access to resources Recommend Favorite

Inhibition of ornithine decarboxylase alters the roscovitine-induced mitochondrial-mediated apoptosis in MCF-7 breast cancer cells

By        

Molecular Medicine Reports, Vol. 5, Iss. 5, 2012-01 ,pp. : 1323-1329

Spandidos Publications

Access to resources Recommend Favorite